Il ruolo del laboratorio clinico nella diagnostica della calcolosi renale
AUTORI
Laboratorio di Chimica Analitica e Calcolosi Renale - Azienda Ospedaliera Ordine Mauriziano di Torino
ABSTRACT
The role of clinical laboratory for the diagnosis of urolithiasis
The pathogenesis of urolithiasis is related to the presence of physico-chemical abnormalities in the urine environment. These anomalies can be highlighted and evaluated through specific biochemical investigations, often not included in the usual activities of a hospital laboratory. The laboratory activities include the adoption of the most appropriate procedures for the evaluation of urine saturation with respect to lithogenic salts (propensity to stone formation), the identification and analysis of precursors and inhibitors of crystallization, the biochemical investigation for the identification of pre-existing diseases, including the genetic ones, and the analysis of kidney stones. Over the years, in the medical approach to nephrolithiasis, the need for specialized analytical techniques has increasingly raised, requiring the use of versatile technology (HPLC, GC-LC/MS, FTIR), adaptable to the investigation of substances belonging to the most varied classes and present in different biological matrices. In this paper we describe the main analytical activities carried out by a specialized laboratory for the study of renal stone disease.
BIBLIOGRAFIA
- Marangella M. Medical management of urinary calculi: up to date 2016. Urologia 2016;83:110-23.
- Tiselius HG. Epidemiology and medical management of stone disease. BJU Int 2003;91:758-67.
- White DJ, Nancollas GH. The kinetics of dissolution of calcium oxalate monohydrate: a constant composition study. J Cryst Growth 1982;57:267-72.
- Desmars JF, Tawashi R. Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH. Biochim Biophys Acta 1973;313:256-67.
- Nancollas GH, Gardner GL. Kinetics of crystal growth of calcium oxalate monohydrate. J Cryst Growth 1974;21:267-76.
- Garside J, Brečević Lj, Mullin JW. The effect of temperature on the precipitation of calcium oxalate. J Cryst Growth 1982;57:233-40.
- Marangella M, Daniele PG, Ronzani M, Sonego S, Linari F. Urine saturation with calcium salts in normal subjects and idiopathic calcium stone-formers estimated by an improved computer model system. Urol Res 1985;13:189-93.
- White DJ, Coyle-Rees M, Nancollas GH. Kinetic factors influencing the dissolution behavior of calcium oxalate renal stones: a constant composition study. Calcif Tissue Int 1988;43:319-27.
- Gvozdev NV, Petrova EV, Chernevich TG, Shustin OA, Rashkovichet LN. Atomic force microscopy of growth and dissolution of calcium oxalate monohydrate (COM) crystals. J Cryst Growth 2004;261:539-48.
- Gill WB, Silvert MA, Roma MS. Supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers determined by a 14C-Oxalate technique. Invest Urol 1974; 12:203-9.
- Pak CY, Hayashi Y, Finlayson B, Chu S. Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J Lab Clin Med 1977;89:891-901.
- Erwin DT, Roberts JA, Sledge G, et al. Estimating urine saturation, a comparision of results of two methods evaluating changes induced by drinking milk. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. New York:Plenum Press 1977;437-40.
- Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB. Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978;50:449-54.
- Pak CY, Maalouf NM, Rodgers K, Poindexter JR. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate. J Urol 2009;182:2951-6.
- Marangella M, Petrarulo M, Vitale C, Daniele P, Sammartano S. LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone. Urolithiasis 2021;49:211-7.
- Ferraro PM, Lopez F, Petrarulo M, Barbarini S, Curhan GC, Marangella M, et al. Estimating 24-hour urinary excretion using spot urine measurements in kidney stone formers. Nephrol Dial Transplant 2022;37:2171-9.
- Kok DJ, Papapoulos SE, Bijvoet OL. Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int 1990;37:51-6.
- Grover PK, Moritz RL, Simpson RJ, Ryall RL. Inhibition of growth and aggregation of calcium oxalate crystals in vitro–a comparison of four human proteins. Eur J Biochem 1998;253:637-44.
- Zeng X, Xi Y, Jiang W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis: A review. Crit Rev Food Sci Nutr 2019;59:2125-35.
- Zuckerman JM, Assimos DG. Hypocitraturia: pathophysiology and medical management. Rev Urol 2009;11:134-44.
- Baker EM, Saari JC, Tolbert BM. Ascorbic acid metabolism in man. Am J Gun Nutr 1966;19:371-8.
- European Association of Urology Guidelines on Urolithiasis. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
- Petrarulo M, Marangella M, Bianco O, Marchesini A, Linari F. Preventing ascorbate interference in ion-chromatographic determinations of urinary oxalate: four methods compared. Clin Chem 1990;36:1642-5.
- Petrarulo M, LeporatiM, Pullara F, Frattini M, Nannavecchia V, Marangella M, et al. Sensitive Ion-chromatographic determination of citric acid in urine. Separations 2022;9:143.
- Brand E, Harris M, Biloon S. Cystinuria: the excretion of cystine which decomposes in the urine with the liberation of free cystine. J Biol Chem 1930;86:315-31.
- Imai K, Toyo’oka T. Fluorometric assay of thiols with fluorobenzoxadiazoles. Methods Enzymol 1987;143:67-75.
- Daudon M, Frochot V, Bazin D, Jungers P. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment. Drugs 2018;78:163-201.
- Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O’Riordan WD, Cochat P, et al. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med 2021;384:1216-26.
